MB, Levis & Associates’s AbbVie ABBV Stock Holding History

MB, Levis & Associates’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$143K	Hold	547	–	–	0.05%	70
2026 Q2	$138K	Hold	547	–	–	0.05%	73
2026 Q1	$119K	Hold	547	–	–	0.05%	71
2025 Q4	$125K	Hold	547	–	–	0.05%	72
2025 Q3	$127K	Hold	547	–	–	0.05%	71
2025 Q2	$102K	Hold	547	–	–	0.04%	88
2025 Q1	$115K	Hold	547	–	–	0.05%	80
2024 Q4	$97.2K	Hold	547	–	–	0.05%	86
2024 Q3	$108K	Hold	547	–	–	0.05%	79
2024 Q2	$93.8K	Hold	547	–	–	0.05%	84
2024 Q1	$100K	Buy	547 +4	+0.7%	+$689	0.05%	85
2023 Q4	$84.2K	Buy	543 +4	+0.7%	+$583	0.05%	88
2023 Q3	$80.3K	Buy	539 +4	+0.7%	+$587	0.05%	91
2023 Q2	$72K	Buy	535 +6	+1%	+$880	0.05%	94
2023 Q1	$84.4K	Buy	529 +5	+1%	+$764	0.06%	88
2022 Q4	$84.7K	Buy	+524	New	+$80.3K	0.07%	82

Other funds holding ABBV

Robeco Institutional Asset Management Rotterdam, Netherlands $83.2B AUM 35.34% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $103B AUM 40.17% 1-Year Est. Return

New York State Teachers Retirement System (NYSTRS) Albany, New York $52.9B AUM 36.03% 1-Year Est. Return

Cardano Risk Management Rotterdam, Netherlands $18.2B AUM 38.97% 1-Year Est. Return

Sepio Capital Salt Lake City, Utah $2.5B AUM 20.77% 1-Year Est. Return

Hamlin Capital Management New York $4.04B AUM 11.59% 1-Year Est. Return

Wealth Enhancement Advisory Services Plymouth, Minnesota $67.3B AUM 21.9% 1-Year Est. Return

Ferguson Wellman Capital Management Portland, Oregon $8.38B AUM 25.07% 1-Year Est. Return

ABN AMRO Investment Solutions Paris Cedex 008 $13.2B AUM 30.55% 1-Year Est. Return

KBC Group Brussels, Belgium $47.9B AUM 37.61% 1-Year Est. Return

MB, Levis & Associates's ABBV Position: Q3 2026 in Review

MB, Levis & Associates held its AbbVie (ABBV) position steady in Q3 2026 at 547 shares worth $143K. The position accounts for 0.05% of the portfolio, ranked #70.

MB, Levis & Associates first reported a position in ABBV in Q4 2022 and has held it in 16 quarters since. 1,297 funds tracked by Wall St. Rank hold ABBV as of Q3 2026.

MB, Levis & Associates held 547 shares of AbbVie worth $143K as of Q3 2026.
MB, Levis & Associates left its AbbVie share count unchanged in Q3 2026.
AbbVie made up 0.05% of MB, Levis & Associates's portfolio in Q3 2026, its #70 holding.
MB, Levis & Associates first reported a position in AbbVie in Q4 2022 and has held it in 16 quarters since.
1,297 funds tracked by Wall St. Rank held AbbVie as of Q3 2026.

Based on MB, Levis & Associates's 13F filing for Q3 2026, filed 16 Oct 2026.